This site is intended for healthcare professionals only
The option to remotely supervise a pharmacy in a crisis as a last resort could be helpful for pharmacists in some situations, says contractor Mike Hewitson
Whether pharmacies can ever be responsibly supervised without a pharmacist on-site has been a key debate in the sector over the last three years. The controversial issue arose again as a result of the pressures on the sector caused by the COVID-19 outbreak.
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
‘Vote no’ campaigner Martin Astbury tells C+D why he believes the RPS plans for change represent a shift away from pharmacist leadership and why members should vote against them this week…
I also read comments that CPE does not appreciate this critical position, and I fundamentally refute that. Knowing the colleagues, both elected and employed, at CPE as I do, this is far from the case.
Community pharmacy is risk adverse, considered, and dare I say it, conservative. But, when it comes to the survival of pharmacy, we can’t afford to let the fear of change – or those resistant to it - hold us back.
Confirmation of the unchanging fees comes as NHS England (NHSE) has asked pharmacies to prepare for the autumn flu and COVID-19 vaccination programmes to start in October, or September for pregnant women.
The new private COVID-19 vaccine, manufactured by Novavax and delivered for the first time in the UK by an independent pharmacy, is almost half the price of the Pfizer jab offered by Boots.
